383P A phase I dose-escalation study of the novel peptide ALM201 in patients (pts) with advanced solid tumours.
El-Helali, A Plummer, R Jayson, Gordon C Coyle, V Drew, Y Mescallado, Nerissa Harris, N Clamp, Andrew R McCann, J Kennedy, R
El-Helali, A
Plummer, R
Jayson, Gordon C
Coyle, V
Drew, Y
Mescallado, Nerissa
Harris, N
Clamp, Andrew R
McCann, J
Kennedy, R
Citations
Altmetric:
Abstract
Description
Date
2017-09
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
383P A phase I dose-escalation study of the novel peptide ALM201 in patients (pts) with advanced solid tumours. 2017, 28(suppl_5): Ann Oncol